You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
Uyar TB, Wu K, He M, et al. (2020) Switchable fluorescence of doxorubicin for label-free imaging of bioorthogonal drug release. Chemmedchem |
Wu K, He M, Khan I, et al. (2019) Bio-orthogonal chemistry-based method for fluorescent labelling of ribosomal RNA in live mammalian cells. Chemical Communications (Cambridge, England) |
Czuban M, Srinivasan S, Yee NA, et al. (2018) Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments against Infections. Acs Central Science. 4: 1624-1632 |
Khan I, Seebald LM, Robertson NM, et al. (2017) Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry. Chemical Science. 8: 5705-5712 |
Robertson NM, Yang Y, Khan I, et al. (2017) Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation. Nanoscale |
Mejia Oneto JM, Khan I, Seebald L, et al. (2016) In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma. Acs Central Science. 2: 476-82 |
Khan I, Agris PF, Yigit MV, et al. (2016) In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles. Chemical Communications (Cambridge, England) |
Agustin E, Asare Okai PN, Khan I, et al. (2015) A fast click-slow release strategy towards the HPLC-free synthesis of RNA. Chemical Communications (Cambridge, England) |
Siddiqui S, Khan I, Zarina S, et al. (2013) Use of the SYBR Green dye for measuring helicase activity. Enzyme and Microbial Technology. 52: 196-8 |
Khan IA, Siddiqui S, Rehmani S, et al. (2012) Fluoroquinolones inhibit HCV by targeting its helicase. Antiviral Therapy. 17: 467-76 |